$1,980.00
We use our efficient, integration-free, small molecule-based method to differentiate high-quality T cells from human iPSCs. The differentiated T cells recapitulate the phenotype and functional parameters of primary and in vivo T cells.
We provide T cells differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from the fibroblasts of an African American male donor. These cells express T cell biomarkers CD4+ and CD8+.
These iPSC-differentiated T cells can be used as control lines to compare phenotype and functionality of patient-derived, genome-edited iPSC-derived T cells for drug screening applications. They can also be used as effector cells for cytotoxicity assays.
| Table Header | Table Header |
|---|---|
|
Age |
Neonate |
|
Gender |
Male |
|
Ethnicity |
African American |
|
Tissue source |
Dermal fibroblasts |
|
Reprogramming method |
Episomal |
|
Culture conditions |
Feeder-free |
